WELCOME TO
BSG LIVE’25
Connect • Learn • Innovate
Industry Symposia – Madrigal Pharmaceuticals
MASH with Fibrosis: Defining Risk and Clinical Pathways for Decision Making
Wednesday 24 June 13:00-13:40
Learning objectives:
- Recognise the burden of disease for patients living with MASH with liver fibrosis
- Summarise a stepwise diagnostic algorithm supporting the identification of patients with non-cirrhotic MASH with moderate to advanced liver fibrosis
- Describe the clinical decision making in MASH
Speakers:
Dr Thomas Marjot – Consultant Hepatologist, King’s College Hospital

